Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSThree Regulatory News (STEM)

Share Price Information for SThree (STEM)

Share Price is delayed by 15 minutes
Get Live Data
157.00    1.20 (0.77%)
Bid:
156.60
Ask:
157.20
Spread: 0.60 (0.383%)
Market Cap: £191.68m
STEM Live PriceLast checked at - London Stock Exchange

Intraday SThree Share Chart

FY24 Q3 Trading Update

24 Sep 2024 07:00

RNS Number : 3194F
SThree plc
24 September 2024
 

24 September 2024

 

SThree plc

 

FY24 Q3 Trading Update

 

Contract extensions continue to underpin performance and full-year visibility

 

SThree plc ("SThree" or the "Group"), the only global specialist talent partner focused on roles in Science, Technology, Engineering and Mathematics ('STEM'), today issues a trading update covering the period 1 June 2024 to 31 August 2024.

 

 

Q3 Highlights

 

·

Group net fees down 8% YoY(1) against the continuing backdrop of challenging market conditions, with Contract down 8%, representing 84% of net fees.

·

Contractor order book(2) down 6% YoY to £167 million, representing sector-leading visibility (c.4 months of net fees).

·

Robust balance sheet with net cash of £45 million at 31 August 2024 (31 August 2023: £83 million), reflective of the timing of certain client payments, with net cash expected to return towards normalised levels over the coming months.

·

Technology Improvement Programme remains on track, with the US and UK live and the deployment in Germany progressing as anticipated.

·

Performance for FY24 currently expected to be in line with market expectations(3).

 

Timo Lehne, Chief Executive, commented:

 

"Despite the challenging conditions in the market, which have extended beyond our industry's expectations, our strategic focus on Contract continues to underpin the Group's competitive positioning. The Contract order book, down 6%, reflects protracted soft new placement activity partially offset by ongoing strong Contract extensions.

 

Supported by a robust financial position, we continue to invest for the future, with the phased implementation of our Technology Improvement Programme being a core element. This is progressing to plan, providing a clear pathway to significant operational enhancements over the mid-to-long term and enabling us to lead the way in our industry.

 

We are ideally positioned at the heart of global STEM secular trends, and we have the right platform for when the market recovers to enable the delivery of long-term sustainable growth."

 

Business performance highlights

 

Against tough market conditions Group net fees were down 8% YoY reflecting the ongoing softness in new business across Contract and Permanent, partially offset by strong Contract extensions.

 

Technology, our largest skill vertical, delivered a sequential improvement in performance, down 7% YoY. Engineering was also down 7% against a record prior year performance, while Life Sciences declined 14% YoY as global activity in that sector remains subdued.

 

Regionally, the Group delivered strong net fee growth in the Middle East and Asia, underpinned by an impressive performance in Japan across all our main skill verticals. Within the Group's three largest markets, which now represent 72% of net fees, Germany delivered a sequential improvement benefitting from the lower rate of decline in demand for Technology skills. Our USA performance reflected declines in Life Sciences and Technology, whilst the Netherlands saw lower levels of demand for Engineering and Technology skills versus record levels in the prior year.

 

The Group remains well placed to respond when market conditions improve, with Group period-end headcount broadly unchanged from the end of the last financial year. The Group continues to maintain a robust balance sheet with net cash of £45 million at 31 August 2024, reflective of the timing of certain client payments, with net cash expected to return towards normalised levels over the coming months.

 

 

 

 

 

 

Q3

Q3

Q3 2024

Q2 2024

Q1 2024

Net fees

2024

2023

YoY (1)

YoY (1)

YoY (1)

Contract

£78.1m

£86.2m

-8%

-6%

-2%

Permanent

£14.6m

£16.8m

-9%

-15%

-21%

GROUP

£92.7m

£103.0m

-8%

-8%

-6%

 

 

 

 

 

 

Regions

DACH (4)

£33.4m

£36.6m

-8%

-10%

-13%

Netherlands (incl. Spain) (5)

£19.0m

£21.5m

-10%

+5%

+8%

Rest of Europe (6)

£15.3m

£17.8m

-13%

-10%

-10%

USA

£20.1m

£22.6m

-10%

-15%

-10%

Middle East & Asia (7)

£4.9m

£4.5m

+20%

+1%

+20%

GROUP

£92.7m

£103.0m

-8%

-8%

-6%

 

 

 

 

 

 

Top five countries

Germany

£29.6m

£32.2m

-7%

-11%

-14%

Netherlands

£16.9m

£20.1m

-15%

-

+6%

UK

£9.6m

£11.6m

-17%

-11%

-7%

USA

£20.1m

£22.6m

-10%

-15%

-10%

Japan

£3.2m

£2.1m

+60%

+16%

+41%

ROW (8)

£13.3m

£14.3m

-6%

-2%

-4%

Group

£92.7m

£103.0m

-8%

-8%

-6%

 

Service mix

Q3 2024

 Q3 2023

 

 

 

Contract

84%

84%

Permanent

16%

16%

Skills mix

Q3 2024

Q3 2023 

 

 

 

Technology

49%

48%

Life Sciences

16%

17%

Engineering

28%

27%

Other

7%

7%

 

 

(1) All YoY growth rates expressed at constant currency.

(2) The contractor order book represents value of net fees until contractual end dates, assuming all contractual hours are worked.

(3) Current consensus PBT expectation is £69.4m for FY24. Source: SThree compiled consensus.

(4) DACH - Germany, Austria and Switzerland.

(5) Netherlands (incl. Spain) - Netherlands and Spain, which is managed from the Netherlands.

(6) Rest of Europe - UK, Belgium, France.

(7) Middle East & Asia - Japan and UAE.

(8) ROW - All other countries we operate in.

 

 

Analyst conference call

 

SThree is hosting a conference call for analysts and investors today at 8.30am to discuss the FY24 Q3 Trading Update. If you would like to register for the conference call, please contact SThree@almastrategic.com.

Forward looking dates

 

The Group will issue its trading update for the year ending 30 November 2024 on 17 December 2024.

 

 

 

Enquiries:

 

 

 

SThree plc

Timo Lehne, CEO

Andrew Beach, CFO

Keren Oser, Investor Relations Director

 

 

 via Alma

Alma Strategic Communications

+44 20 3405 0205

 

Rebecca Sanders-Hewett

Hilary Buchanan

Sam Modlin

Will Ellis Hancock

SThree@almastrategic.com

 

 

Notes to editors

SThree plc brings skilled people together to build the future. We are the only global specialist talent partner focused on roles in Science, Technology, Engineering and Mathematics ('STEM'), providing permanent and flexible contract talent to a diverse base of over 5,400 clients (with whom we worked in the Q3 year to date period) across 11 countries. Our Group's c.2,600 staff cover the Technology, Life Sciences and Engineering sectors. SThree is part of the Industrial Services sector. We are listed on the London Stock Exchange's Main Market, trading with ticker code STEM.

 

Important notice

Certain statements in this announcement are forward looking statements. By their nature, forward looking statements involve a number of risks, uncertainties or assumptions that could cause actual results or events to differ materially from those expressed or implied by those statements. Forward looking statements regarding past trends or activities should not be taken as representation that such trends or activities will continue in the future. Certain data from the announcement is sourced from unaudited internal management information and is before any exceptional items. Accordingly, undue reliance should not be placed on forward looking statements.

 

 

 

 

 

 

 

 

 

 

- Ends -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQKNBPABKDBCB
Date   Source Headline
10th Mar 20264:12 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 202611:00 amRNSAnnual Financial Report
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20264:37 pmRNSDirector/PDMR Shareholding
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 202611:15 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 202612:15 pmRNSDirector/PDMR Shareholding
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSCommencement of Share Buyback Programme
2nd Feb 20261:24 pmRNSTotal Voting Rights
27th Jan 20267:00 amRNSFY25 Final Results
13th Jan 20269:08 amRNSDirector/PDMR Shareholding
2nd Jan 202611:56 amRNSTotal Voting Rights
2nd Jan 202611:45 amRNSPurchase of shares into the EBT
2nd Jan 202610:56 amRNSHolding(s) in Company
19th Dec 20254:23 pmRNSHolding(s) in Company
19th Dec 20254:23 pmRNSHolding(s) in Company
19th Dec 20254:19 pmRNSDirector/PDMR Shareholding
19th Dec 20254:19 pmRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSFY25 Full Year Trading Update
15th Dec 20252:11 pmRNSHolding(s) in Company
15th Dec 202510:14 amRNSDirector/PDMR Shareholding
11th Dec 20254:28 pmRNSHolding(s) in Company
9th Dec 20255:35 pmRNSHolding(s) in Company
1st Dec 202512:14 pmRNSTotal Voting Rights
26th Nov 20258:00 amRNSDirector Declaration
26th Nov 20257:00 amRNSDirectorate change
13th Nov 20253:40 pmRNSDirector/PDMR Shareholding
7th Nov 20253:57 pmRNSHolding(s) in Company
31st Oct 202511:42 amRNSTotal Voting Rights
24th Oct 20259:37 amRNSHolding(s) in Company
22nd Oct 20251:03 pmRNSHolding(s) in Company
14th Oct 20254:28 pmRNSDirector/PDMR Shareholding
6th Oct 202511:04 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.